Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Wed, 24.04.2024
Cherry SE
Munich, 24. April 2024 - Cherry SE corrects old assumptions about the company's development and carries out conservative, non cash-effective revaluations
Cherry SE is recognizing asst impairments in the 2023 annual financial statements. These non-cash items relate to intangible assets, mainly goodwill, as well as property, plant and equipment and [ … ]
Wed, 24.04.2024
Cherry SE
PUBLICATION OF AN INSIDE INFORMATION ACC. TO ARTICLE 17 OF THE REGULATION (EU) NO. 596/2014
Cherry SE recognizes asset impairment for 2023; no impact on preliminary adjusted 2023 EBITDA and cash flow position as well as the forecast for the 2024 financial year
Munich, April 24 2024 – Cherry SE expects further asset impairments (intangible assets, [ … ]
Wed, 24.04.2024
SIMONA Aktiengesellschaft
EBIT close to prior-year record – Group revenue down 16% on the back of sluggish global economy – Muted start to 2024
Kirn, 24 April 2024. In what proved to be a dynamic year, the SIMONA Group recorded solid earnings against the backdrop of difficult global economic conditions. Group revenue fell by 15.7 per cent to €600.0 million amid weak demand. [ … ]
Wed, 24.04.2024
Edison Investment Research Limited
London, UK, 24 April 2024
Edison issues initiation on International Public Partnerships (INPP): Consistently and responsibly delivering
International Public Partnerships’ (INPP’s) FY23 results show that it continues to deliver consistent and predictable returns for investors, while delivering environmental and social benefits for the indivi [ … ]
Wed, 24.04.2024
Cembra Money Bank AG
Cembra Money Bank AG
/ Key word(s): AGMEGM
Cembra shareholders approve all proposals of the Board of Directors
24.04.2024 / 15:55 CET/CEST
Zurich, 24 April 2024 – The Annual General Meeting 2024 of the Swiss bank Cembra was held in Zurich today. 304 shareholders attended the meeting, representing 14,665,422 registered s [ … ]
Wed, 24.04.2024
ElringKlinger AG
Minister-President Winfried Kretschmann visits ElringKlinger
Tour of the competence center for battery technology in Neuffen
Intensive exchange with ElringKlinger CEO Thomas Jessulat on the transformation of the automotive and supplier industry
Symbolic groundbreaking ceremony for new logistics center at the Neuffen plant
Dettingen/Erms (Germany [ … ]
Wed, 24.04.2024
Highlight Communications AG
PRESS RELEASE
Highlight Group publishes results for fiscal year 2023
Consolidated sales amounted to CHF 421.3 million in the financial year (previous year: CHF 523.8 million), due to production-related factors in the Film segment
Due to foreign-currency effects, EBIT amounts to CHF 6.9 million
Consolidated net profit for the period attributabl [ … ]
Wed, 24.04.2024
HOWOGE Wohnungsbaugesellschaft mit beschränkter Haftung
NOT FOR PUBLICATION, DISTRIBUTION OR FORWARDING, EITHER DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL.
HOWOGE acquires around 4,500 apartments and secures land reserves for building public housing
Berlin, 24 Apr [ … ]
Wed, 24.04.2024
CureVac
CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Business Update
Organizational redesign and rightsizing initiated across company to streamline structures, increase efficiency and reduce operating costs
Together with GSK, ended Pandemic Preparedness Agreement (PPA) with Federal Republic of Germany, a [ … ]
Wed, 24.04.2024
CureVac
CureVac Announces Start of Combined Phase 1/2 Study in Avian Influenza (H5N1); Development in Collaboration with GSK
Phase 1 part of combined Phase 1/2 study initiated as part of pandemic preparedness against highly pathogenic avian influenza (H5N1) virus, considered to be potential future pandemic threat
Study will assess monovalent vaccine ca [ … ]